We present a 61-year-old man who was diagnosed with synchronous prostate cancer and suspicious renal cell carcinoma of the right kidney, treated with combined Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) and robot-assisted partial nephrectomy (RAPN). The combined approach using RS-RARP and RAPN is technically feasible and safe surgical option for treatment of concomitant prostate cancer and suspicious renal cell carcinoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791664PMC
http://dx.doi.org/10.4111/icu.2016.57.2.146DOI Listing

Publication Analysis

Top Keywords

retzius-sparing robot-assisted
8
robot-assisted radical
8
radical prostatectomy
8
partial nephrectomy
8
prostate cancer
8
cancer suspicious
8
suspicious renal
8
renal cell
8
cell carcinoma
8
simultaneous retzius-sparing
4

Similar Publications

Introduction: The Retzius-sparing technique for prostate cancer has shown favorable continence recovery outcomes. Magnetic resonance imaging after Retzius-sparing showed that the bladder anterior wall is widely connected to the abdominal wall, which contributes to urinary continence. We aimed to evaluate whether the Peritoneal Fixation technique, which involves suturing the anterior bladder wall onto the abdominal wall above the pubic bone, contributes to the recovery of urinary continence.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the two-year functional and oncological outcomes of Retzius-sparing robot-assisted laparoscopic prostatectomy (rsRALP) vs. standard robot-assisted laparoscopic prostatectomy (sRALP) in patients with localized prostate cancer.
  • Results show that rsRALP significantly improves urinary function and quality of life over time, while sexual function differences were negligible after 12 months.
  • Although rsRALP had some negative surgical margin characteristics, it did not affect biochemical recurrence rates after five years, indicating no significant difference in long-term oncological outcomes between the two methods.
View Article and Find Full Text PDF

Background: The aim of this study is to describe the first series of six patients undergoing Retzius-sparing robot-assisted radical prostatectomy (rs-RARP) using the hinotori surgical robot system (hinotori SRS) and to compare the treatment outcomes with those achieved with the da Vinci surgical platform.

Methods: This study included 20 cases involving the rs-RARP procedure (hinotori: N = 6; da Vinci: N = 14) that were performed between May 2021 and April 2024 in a single institution.

Results: No significant differences were observed between the hinotori and da Vinci groups regarding the preoperative findings.

View Article and Find Full Text PDF

This study aimed to construct a novel pelvis-prostate model BPPP which consists of body mass index (BMI), prostate volume (PV), pelvic cavity index (PCI) and prostate-muscle index (PMI) to predict the immediate urinary continence after Retzius-sparing robot assisted laparoscopic radical prostatectomy (RS-RARP). The perioperative data of patients with prostate cancer who underwent RS-RARP in the department of urology of Nanjing Drum Tower Hospital from June 2018 to June 2022 were retrospectively analyzed. 280 patients were eligible for this study in total.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!